Aggregated News
Genetics is more complex than scientists imagined. We have discovered highly predictive genes for about 2,000 rare ailments, such as Huntington’s disease, but not for most common diseases such as cancer and diabetes. This hasn’t prevented companies such as 23andMe Inc. from selling direct-to-consumer genetic testing, with claims that it offers beneficial health information.
Debates about the information these companies are providing boiled over last week after the Food and Drug Administration, which is responsible for ensuring that medications, medical devices and tests are safe and effective, sent a letter to 23andMe, demanding that the company stop selling its $99 genetic test kit. On Monday, 23andMe stopped marketing its test kit.
On its website, 23andMe still boasts that its kit “reports on 240+ health conditions and traits.” A small proportion of this information -- as it relates to breast cancer mutations, for example --...